Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10799714 | Biochimica et Biophysica Acta (BBA) - General Subjects | 2016 | 42 Pages |
Abstract
The accumulated data indicate that carefully controlled additional investigations in humans are merited. The focus should be on the long-term use of betaine in large patient populations with liver diseases characterized by development of fatty liver, especially non-alcoholic fatty liver disease and alcoholic liver disease.
Keywords
BHMTSNATOCTN2S-adenosylhomocysteineAMPKBGT1betaine/GABA transporterSAHDmgMethionine cycleNAFLDSAMAMP-activated protein kinaseALDS-adenosylmethionineNon-alcoholic steatohepatitisAlcoholbetaine–homocysteine methyltransferasealcoholic liver diseasenon-alcoholic fatty liver diseasedimethylglycineMethyltransferaseNash Hepatocyteorganic cation/carnitine transporterFatty liver
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Christopher R. Day, Stephen A. Kempson,